PER 0.00% 10.5¢ percheron therapeutics limited

For General Information, page-3016

  1. 13,424 Posts.
    lightbulb Created with Sketch. 1439
    If ANP was protected against all future uses of ATL1102 by third parties (others needing to licence to them), why would they still be writing ATL1102 methods of use patents and so careful as not to divulge anything prior to lodging them?

    Boomy your post above.
    ok
    So Anp do not want to divulge any information that others can use before Anp can register their patent.: once the patent is pending approval it’s safe .

 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.